A Phase 1 Dose Escalation Study of VX-708 in Healthy Participants
Clinical trial NCT05518734 · COMPLETED
Trial details
- NCT number
- NCT05518734
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-17
- Primary completion
- 2023-03-07
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.